1Center for Women's Health, Mayo Clinic, Rochester, MN
2Division of General Internal Medicine, Mayo Clinic, Rochester, MN
3Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, Rochester, MN
4Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN
5Atherosclerosis Research Unit, Departments of Medicine and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
6Departments of Surgery and Physiology & Biomedical Engineering, Women's Health Research Center, Mayo Clinic, Rochester, MN.
Address correspondence to: Stephanie S. Faubion, MD, 200 First Street SW, Rochester, MN 55905. E-mail: [email protected]
Received 4 April, 2019
Revised 7 July, 2019
Accepted 7 July, 2019
Sources of funding: This study was funded in part by NIH grants awarded to Drs. Hodis and Miller. Dr. Kapoor is also partially supported by the NIH. (NIH Grant - U54 AG044170 - Sex-Specific Effects of Endocrine Disruption on Aging and Alzheimer's Disease).
Financial disclosure/conflicts of interest: SSF consults for AMAG, Mithra Pharmaceuticals, and Procter & Gamble. The other authors have no conflicts to disclose.
Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Website (www.menopause.org).
